Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Milica Borovčanin

Biographic Data

ID7654584
NAMEMilica Borovčanin
GIVEN NAMESMilica
FAMILY NAMEBorovčanin
SIGNATUREBOROVČANIN M
AFFILIATIONSUniversity of Kragujevac
ORCID0000-0002-2992-814X
VERIFIEDYes
TOTAL WORKS5
TOTAL CITATIONS0
AUTHOR COUNT5
EDITOR COUNT0
FIRST PUBLICATION YEAR2018
LATEST PUBLICATION YEAR2022
H-INDEX0
  • Prescription of selective serotonin reuptake inhibitors in Covid-19 infection needs caution

    Open Access•Milica Borovčanin, Milica M Borovcanin et al.•ARTICLE•Frontiers in Psychiatry•2022

    OPINION article Front. Psychiatry, 19 October 2022Sec. Molecular Psychiatry Volume 13 - 2022 | https://doi.org/10.3389/fpsyt.2022.1052710

  • Uric Acid Potential Role in Systemic Inflammation and Negative Symptoms After Acute Antipsychotic Treatment in Schizophrenia

    Open Access•Milica Borovčanin, Milica M Borovcanin et al.•ARTICLE•Frontiers in Psychiatry•2022

    Uric acid (UA) has been shown to have neuroprotective or neurotoxic properties, in relation to specific tissues and diseases that have been studied. Previous studies provided contradictory results on the role of UA in schizophrenia as a neurodegenerative disorder. The aim of this brief report was an additional analysis of UA sera levels in different phases of schizophrenia. Here, 86 patients with first-episode psychosis (FEP) vs. 45 patients with…

  • Psychiatry Trainees' Attitudes, Knowledge, and Training in Addiction Psychiatry—A European Survey

    Open Access•Laura Orsolini, Irena Rojnić Palavra et al.•ARTICLE•Frontiers in Psychiatry•2021

    Background: Although psychoactive substance use disorders (PSUDs) are a domain of mental health, addiction psychiatry is only formally recognized as a subspecialty in a few European countries, and there is no standardized training curriculum. Methods: A 76-item questionnaire was developed and disseminated through an online anonymous data-collecting system and hand-to-hand amongst psychiatric trainees from the 47 European countries of the Council …

  • Chlorpromazine as a Potential Antipsychotic Choice in Covid-19 Treatment

    Open Access•Nemanja Murić, Nemanja N Muric et al.•ARTICLE•Frontiers in Psychiatry•2020

    OPINION article Front. Psychiatry, 23 December 2020Sec. Psychopharmacology Volume 11 - 2020 | https://doi.org/10.3389/fpsyt.2020.612347

  • IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis

    Open Access•Milica Borovčanin, Milica M Borovcanin et al.•ARTICLE•Frontiers in Psychiatry•2018

    Schizophrenia and treatment of this disorder are often accompanied with metabolic syndrome and cardiovascular issues. Alterations in the serum level of innate immune mediators, such as interleukin-33 (IL-33) and its receptor IL-33R (ST2) and Galectin-3 (Gal-3) were observed in these conditions. Moreover, these parameters are potential prognostic and therapeutic markers. There is also accumulating evidence that these molecules play a role in neuro…

No prominent works on this page.

  • IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis

    Open Access•Milica Borovčanin, Milica M Borovcanin et al.•ARTICLE•Frontiers in Psychiatry•2018

    Schizophrenia and treatment of this disorder are often accompanied with metabolic syndrome and cardiovascular issues. Alterations in the serum level of innate immune mediators, such as interleukin-33 (IL-33) and its receptor IL-33R (ST2) and Galectin-3 (Gal-3) were observed in these conditions. Moreover, these parameters are potential prognostic and therapeutic markers. There is also accumulating evidence that these molecules play a role in neuro…

  • Chlorpromazine as a Potential Antipsychotic Choice in Covid-19 Treatment

    Open Access•Nemanja Murić, Nemanja N Muric et al.•ARTICLE•Frontiers in Psychiatry•2020

    OPINION article Front. Psychiatry, 23 December 2020Sec. Psychopharmacology Volume 11 - 2020 | https://doi.org/10.3389/fpsyt.2020.612347

  • Psychiatry Trainees' Attitudes, Knowledge, and Training in Addiction Psychiatry—A European Survey

    Open Access•Laura Orsolini, Irena Rojnić Palavra et al.•ARTICLE•Frontiers in Psychiatry•2021

    Background: Although psychoactive substance use disorders (PSUDs) are a domain of mental health, addiction psychiatry is only formally recognized as a subspecialty in a few European countries, and there is no standardized training curriculum. Methods: A 76-item questionnaire was developed and disseminated through an online anonymous data-collecting system and hand-to-hand amongst psychiatric trainees from the 47 European countries of the Council …

  • Prescription of selective serotonin reuptake inhibitors in Covid-19 infection needs caution

    Open Access•Milica Borovčanin, Milica M Borovcanin et al.•ARTICLE•Frontiers in Psychiatry•2022

    OPINION article Front. Psychiatry, 19 October 2022Sec. Molecular Psychiatry Volume 13 - 2022 | https://doi.org/10.3389/fpsyt.2022.1052710

  • Uric Acid Potential Role in Systemic Inflammation and Negative Symptoms After Acute Antipsychotic Treatment in Schizophrenia

    Open Access•Milica Borovčanin, Milica M Borovcanin et al.•ARTICLE•Frontiers in Psychiatry•2022

    Uric acid (UA) has been shown to have neuroprotective or neurotoxic properties, in relation to specific tissues and diseases that have been studied. Previous studies provided contradictory results on the role of UA in schizophrenia as a neurodegenerative disorder. The aim of this brief report was an additional analysis of UA sera levels in different phases of schizophrenia. Here, 86 patients with first-episode psychosis (FEP) vs. 45 patients with…

Medicine (5 works) · Psychiatry (5 works) · Internal Medicine (4 works) · Schizophrenia (object-oriented programming (4 works) · Psychology (3 works) · Tryptophan and brain disorders (3 works) · 2019-20 coronavirus outbreak (2 works) · Antipsychotic (2 works) · Coronavirus disease 2019 (COVID-19 (2 works) · Long-Term Effects of COVID-19 (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae